BHC BHC ボシュ・ヘルス・カンパニ―ズ

 BHCのチャート


 BHCの企業情報

symbol BHC
会社名 Bausch Health Companies Inc (BHC ボシュ・ヘルス・カンパニ―ズ)
分野(sector)   
産業(industry)   
業種 医薬品   医療関連(Health Care)
概要 事業概要 バウシュ・ヘルス・カンパニズ(Bausch Health Companies Inc)(旧名:Valeant Pharmaceuticals International Inc)は医薬品、医療機器および市販商品を開発、製造、販売するカナダ会社である。同社は主に目の健康、消化器、皮膚科の治療分野で製品を開発する。皮膚科製品は光線性角化症、座瘡、アトピー性皮膚炎、乾癬および他の皮膚病を治療する。また、顔のしわ、にきび、色素沈着、レーザー脱毛などの症状に対応する美容医療機器の選択肢も提供する。胃腸(GI)セグメントはGIおよび肝性脳症、下痢および潰瘍性大腸炎を伴う過敏性腸症候群を含む肝臓病態を治療する製品を提供する。目の健康製品は、コンタクトレンズ、医薬品および外科などのカテゴリーで販売される。  バレアント・ファ―マシュ―ティカルズ・インタ―ナショナルは、カナダ医薬品・医療機器メ―カ―。医薬品、市販薬、コンタクトレンズ・眼内レンズ・眼科手術用機器を含む医療機器の開発、製造、販売に従事する。事業は、市場開発と新興成長市場に分かれ、米国、プエルトリコ、カナダ、ポ―ランド、ロシアで販売する。  Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.
本社所在地 514 744-6792
代表者氏名 Joseph C. Papa
代表者役職名 Chairman of the Board Chief Executive Officer
電話番号 +1 514-744-6792
設立年月日 1987年
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 21100人
url www.bauschhealth.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 3318.00000
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 8672.64400
売上高 売上高(百万ドル) 8380.00000
企業価値(EV) 企業価値(EV)(百万ドル) 32256.64400
当期純利益 当期純利益(百万ドル) -4148.00000
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Bausch Health Companies Inc revenues decreased 4% to $8.38B. Net loss before extraordinary items totaled $4.15B vs. income of $1.43B. Revenues reflect Bausch + Lomb / International segment decrease of 4% to $4.66B U.S. Diversified Products segment decrease of 3% to $1.34B United States and Puerto Rico segment decrease of 4% to $5.01B Other Foreign Countries segment decrease of 11% to $1.04B.

 BHCのテクニカル分析


 BHCのニュース

   Piper Sandler Weighs in on Bausch Health Companies Inc’s Q4 2020 Earnings (NYSE:BHC)  2020/10/23 14:17:32 Transcript Daily
Bausch Health Companies Inc (NYSE:BHC) – Piper Sandler reduced their Q4 2020 earnings estimates for shares of Bausch Health Companies in a research report issued to clients and investors on Wednesday, October 21st. Piper Sandler analyst D. Amsellem now forecasts that the company will post earnings per share of $1.22 for the quarter, down from […]
   Stock Traders Purchase High Volume of Call Options on Bausch Health Companies (NYSE:BHC)  2020/10/23 05:50:42 Zolmax News
Bausch Health Companies Inc (NYSE:BHC) was the target of unusually large options trading on Wednesday. Stock investors bought 43,703 call options on the company. This represents an increase of approximately 110% compared to the typical volume of 20,810 call options. BHC has been the subject of a number of analyst reports. Bank of America upgraded […]
   Salix To Present Data For Products Across Its Portfolio At The American College Of Gastroenterology 2020 Virtual Annual Meeting  2020/10/22 11:00:00 PR Newswire
Eleven Scientific Posters to be Featured LAVAL, QC, Oct. 22, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology (GI) business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the world…
   Short Interest in Bausch Health Companies Inc (NYSE:BHC) Grows By 17.0%  2020/10/22 07:50:41 Zolmax News
Bausch Health Companies Inc (NYSE:BHC) saw a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 19,300,000 shares, an increase of 17.0% from the September 15th total of 16,500,000 shares. Based on an average daily volume of 4,470,000 shares, the short-interest ratio is presently 4.3 […]
   Skin Tightening Market 2020 Indepth Study Including COVID 19 Update with of Top Key Players Profile: Merz Pharma, Bausch Health Companies Inc, Hologic, Inc, Cutera, Venus Concept, ALLERGAN  2020/10/21 19:20:41 OpenPR
Data Bridge Market Research has recently added a concise research on the Skin Tightening Market - Industry Trends and Forecast to 2026. Skin Tightening Market research report has been prepared with a nice combination of industry insight, smart solutions, practical
   Piper Sandler Weighs in on Bausch Health Companies Inc’s Q4 2020 Earnings (NYSE:BHC)  2020/10/23 14:17:32 Transcript Daily
Bausch Health Companies Inc (NYSE:BHC) – Piper Sandler reduced their Q4 2020 earnings estimates for shares of Bausch Health Companies in a research report issued to clients and investors on Wednesday, October 21st. Piper Sandler analyst D. Amsellem now forecasts that the company will post earnings per share of $1.22 for the quarter, down from […]
   Stock Traders Purchase High Volume of Call Options on Bausch Health Companies (NYSE:BHC)  2020/10/23 05:50:42 Zolmax News
Bausch Health Companies Inc (NYSE:BHC) was the target of unusually large options trading on Wednesday. Stock investors bought 43,703 call options on the company. This represents an increase of approximately 110% compared to the typical volume of 20,810 call options. BHC has been the subject of a number of analyst reports. Bank of America upgraded […]
   Salix To Present Data For Products Across Its Portfolio At The American College Of Gastroenterology 2020 Virtual Annual Meeting  2020/10/22 11:00:00 PR Newswire
Eleven Scientific Posters to be Featured LAVAL, QC, Oct. 22, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") and its gastroenterology (GI) business, Salix Pharmaceuticals, ("Salix"), one of the largest specialty pharmaceutical companies in the world…
   Short Interest in Bausch Health Companies Inc (NYSE:BHC) Grows By 17.0%  2020/10/22 07:50:41 Zolmax News
Bausch Health Companies Inc (NYSE:BHC) saw a large increase in short interest during the month of September. As of September 30th, there was short interest totalling 19,300,000 shares, an increase of 17.0% from the September 15th total of 16,500,000 shares. Based on an average daily volume of 4,470,000 shares, the short-interest ratio is presently 4.3 […]
   Skin Tightening Market 2020 Indepth Study Including COVID 19 Update with of Top Key Players Profile: Merz Pharma, Bausch Health Companies Inc, Hologic, Inc, Cutera, Venus Concept, ALLERGAN  2020/10/21 19:20:41 OpenPR
Data Bridge Market Research has recently added a concise research on the Skin Tightening Market - Industry Trends and Forecast to 2026. Skin Tightening Market research report has been prepared with a nice combination of industry insight, smart solutions, practical
   The Week Ahead In Biotech: Conference Presentations, IPOs In The Mix  2020/09/21 01:16:35 Benzinga
Biotech stocks found themselves among gains in the week ended Sept. 18, with conference presentations, IPO news flow and updates on coronavirus vaccine/antibody candidates catalyzing some strong moves. A big-ticket M&A was announced at the start of the week. Gilead Sciences Inc. (NASDAQ: GILD agreed to buy Immunomedics Inc. (NASDAQ: IMMU ), which has a commercial antibody drug conjugate in the market. Three biopharma companies and a dialysis equipment maker debuted on Wall Street, with the former group raising combined gross proceeds of $522 million. Here're the catalytic events for the unfolding week: Conferences 56th annual meeting of the European Association for the Study of Diabetes, or EASD: Sept. 21-25 2020 American Academy of Neurology Science Highlights: Sept. 23-24 14th annual Sickle Cell Disease Research and Educational Symposium and 43rd National Sickle Cell Disease Scientific Meeting (virtual event): Sept. 23-25 PDUFA Dates The FDA could announce its decision on Bausch Health Companies Inc's (NYSE: BHC ) NDA for EM-100, …
   Bausch Health Companies Inc. (BHC) Management Presents at Morgan Stanley Global Healthcare Conference Call Transcript  2020/09/18 00:03:07 Seeking Alpha
Bausch Health Companies Inc. (NYSE:BHC) Morgan Stanley Global Healthcare Conference September 16, 2020 13:15 ET Corporate Participants Joe Papa - Chairman and Chief Executive Officer Paul Herendeen - Chief Financial Officer Conference Call Participants Dave Risinger - Morgan Stanley Presentation Dave Risinger Great.
   Bausch Health (BHC) Presents At Morgan Stanley 18th Annual Global Healthcare Conference - Slideshow (NYSE:BHC)  2020/09/17 23:18:49 Seeking Alpha
The following slide deck was published by Bausch Health Companies Inc. in conjunction with this event..
   Global Eyewear Market- Featuring Bausch Health Companies Inc, Carl Zeiss AG, and De Rigo Vision Spa Among Others  2020/09/16 14:30:00 Business Wire
LONDON--(BUSINESS WIRE)-- #EyewearMarket--The Global Eyewear Market will grow by USD 57.69 bn during 2020-2024
   Bausch Health Provides Company Update At 18th Annual Morgan Stanley Global Healthcare Conference  2020/09/16 11:00:00 PR Newswire
LAVAL, Quebec, Sept. 16, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced it has published a presentation that Joseph C. Papa, chairman and CEO, and Paul S. Herendeen, executive vice president and chief financial officer,…

 関連キーワード  (医薬品 米国株 BHC ボシュ・ヘルス・カンパニ―ズ BHC )

 twitter  (公式ツイッターやCEOツイッターなど)